Dr. Solensky is a leader in the development and publication of allergy/immunology practice parameters, which are the gold standard guidelines for physicians on how to practice allergy/immunology. He has also published numerous original articles, review articles and book chapters in the areas of drug allergy, food allergy, and anaphylaxis.
He is on the editorial board of “Annals of Allergy, Asthma and Immunology” and “Journal of Allergy and Clinical Immunology: In Practice” and serves as a referee and reviewer for several other prestigious allergy and immunology journals.
Dr. Solensky is an internationally-recognized expert in drug allergy. He frequently gives presentations at international, national, state and local medical conferences.
Outside his practice, he enjoys tennis and outdoor activities.
Fellowship
Allergy/Immunology, UT Southwestern Medical Center, Dallas TX, 2000
Residency
Pediatrics, UCSD Medical Center, San Diego, CA, 1998
Education
M.D., Mount Sinai School of Medicine, New York, NY, 1995
Certification
American Board of Allergy/Immunology, American Board of Pediatrics
Clinical Research
2015: D2210C0007A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist (STRATOS 1)
2014: MEDI 563 D3250C00018: A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Asthmatic Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist (CALIMA)
2013: A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinoconjunctivitis With or Without Asthma.
2012: Confirmatory Study to Examine Negative Predictive Value (NPV) and Safety of Skin Testing with PRE-PEN, a Minor Determinant Mixture (MDM) ofPenicillin Antigens, and Amoxicillin Reagent Against an Oral Challenge with Amoxicillin.
2011: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Grass (Phleum pratense) Sublingual Tablet (SCH 697243) in Subjects Between 5 and 65 Years of Age, With a History of Grass Pollen-Induced Rhinoconjunctivitis, With or Without Asthma
2008: A Phase 3, Randomized, Active-Controlled, Modified Double-Blind Trial, Evaluating the Safety, Tolerability, and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared With a 23-Valent Pneumococcal Polysaccharide Vaccine (23vPS) in Ambulatory Elderly Individuals Aged 70 Years and Older Who Received 1 Dose of 23vPS at Least 5 Years Before Study Enrollment
2007: An open label, single arm study to assess the safety and immunogenicity of the omalizumab liquid pre-filled safety syringe (75 mg or 150 mg) administered subcutaneously over a period of 6 months to adolescents and adults with moderate to severe persistent allergic asthma. Protocol CIGE025C2303. Novartis Pharmaceuticals.
2002: Clinical Investigator Training, The Corvallis Clinic, P.C., Corvallis, OR
2004: Primary Investigator; Daulat SB, Solensky R, Earl H, Casey W, Gruchalla R. Safety of cephalosporin administration to patients with histories of penicillin allergy. J Allergy ClinImmunol 2004; 113:1220-2.
2000: Primary Investigator; Solensky R, Earl HS, Gruchalla RS. Penicillin allergy: Prevalence of vague history in skin test-positive patients. Ann Allergy Asthma Immunol 2000; 85:195-199.
2000: Primary Investigator; Solensky R, Earl HS, Gruchalla RS. Penicillin resensitization in patients with a history of penicillin allergy. J Allergy Clin Immunol 2000; 105:S272-273. Presented at AAAAI 2000 Annual Meeting.
1999: Primary Investigator; Solensky R, Earl HS, Gruchalla RS. Clinical approach to penicillin allergic patients – A survey. J Allergy Clin Immunol 1999: 103:S33. Presented at AAAAI 1999 Annual Meeting; chosen as “media-newsworthy”, participated in press conference.
Abstracts
Darter AL, Solensky R., Earl HS, Gruchalla RS. “Lack of penicillin resensitization in patients with a history of penicillin allergy after repeated penicillin courses during illness. Ann Allergy Asthma Immunol 2003; 90:150-1. Presented at ACAAI 2002 Meeting
Daulat SB, Solensky R, Earl H. Gruchalla R. “Safety of cephalosporin administration to patients with histories of penicillin allergy.” J Allergy Clin Immunol 2002; 109:S268. Presented at AAAAI 2002 Annual Meeting
Solensky R. The time for penicillin skin testing is here (editorial). J Allergy Clin Immunology: In Practice 2013; 1:264-5.
- Solensky R. Allergy to b-lactam antibiotics. J Allergy Clin Immonol 2012; 130:1442-1442e5.
- Solensky R. Hypersensitivity reactions to macrolides, aminoglycosides, teracyclines, clindamycin, and metronidazole. In: UpToDate, Basow, DS (Editor), UpToDate, Waltham, MA 2012-present.
Solensky R, Earl HS, Gruchalla RS. “Penicillin resensitization in patients with a history of penicillin allergy.” J Allergy Clin Immunol 2000; 105:S272-273. Presented at AAAAI 2000 Annual Meeting
Solensky R, Empedrad R, Gruchalla RS. “Pyridium-induced anaphylaxis: A case report.” Ann Allergy Asthma Immunol 2000; 84:117. Presented at ACAAI 1999 Annual Meeting
Empedrad RB, Solensky R, Earl H, Gruchalla RS. “Voluntary reporting of adverse drug reactions (ADRs) significantly underestimes actual ADRs in hospitalized patients.” Ann Allergy Asthma Immunol 2000; 84:149. Presented at ACAAI 1999 Annual Meeting
Solensky R, Earl HS, Gruchalla RS. “Clinical approach to penicillin allergic patients – A survey.” J Allergy Clin Immunol 1999; 103:S33. Presented at AAAAI 1999 Annual Meeting; chosen as “media-newsworthy”, participated in press conference.
Solensky R, Earl HS, Gruchalla RS. “Penicillin allergy: High prevalence of vague history in skin test-positive patients.” Ann Allergy Asthma Immunol 1999; 82:94. Presented at ACAAI 1998 Annual Meeting
Selected Presentations
”Office Evaluation of Patients with Multiple Antibiotic Allergies” (Seminar) AAAAI Annual Meeting. San Antonio TX. 02/2013.
“Evaluation of Antibiotic Allergies: Dilemmas and Solutions” (Symposium) AAAAI Annual Meeting. San Diego, CA. 2/2007.
“Drug Hypersensitivity” Northwest Allergy Forum. Portland, OR. 10/2007
“Drug and Antibiotic Sensitivity” (Workshop), AAAAI Annual Meeting, Philadelphia, 3/2008
“Allergic Cross-Reactivity Between Penicillin’s and Cephalosporins is Not a Concern” (Pro-Con Debate), AAAAI Annual Meeting. Philadelphia, 3/2008
“Asthma Update 2008”. Grand Rounds. Good Samaritan Regional Medical Center, Corvallis, OR 9/2008
“Drug Allergies”. (Allied Health Professionals Course), ACAAI Annual Meeting. Seattle, WA 11/2008
“Antibiotics: Desensitization or Graded Challenge”. (Workshop) AAAAI Annual Meeting. Washington DC, 3/2009
“Pediatric Asthma” Grand Rounds. Albany General Hospital; OR, 4/2009
“Elective Penicillin Skin Testing vs. Testing Only at Time of Need” (Pro-Con Debate) AAAAI Annual Meeting. New Orleans, LA. 02/2010
“Multiple Drug Allergy Syndrome: Evaluation and Management” (Workshop) AAAAI Annual Meeting. New Orleans, LA. 02/2010.
“Drug Allergy: An Updated Practice Parameter: What’s New – Antibiotics” (Symposium) AAAAI Annual Meeting. New Orleans, LA. 02/2010.
“The Ins and Outs of Penicillin Allergy and Penicillin Skin Testing” Northwest Society of Allergy Nurses Annual Meeting. Seaside, OR. 10/2010.
“Graded Challenge vs. Desensitization for Drug Allergy” Northwest Allergy Forum. Woodenville, WA. 10/2010.
“What the Allied Health Professional Needs to Know about Drug Hypersensitivity” (Workshop) AAAAI Annual Meeting. San Francisco, CA. 03/2011.
“Outpatient Evaluation of Patients with Multiple Drug Allergy Syndrome’ (Seminar) AAAAI Annual Meeting. San Francisco, CA. 03/2011.
“Difficult Drug Allergy Cases: Multiple Antibiotic Allergies” (Workshop) AAAAI Annual Meeting. San Francisco, CA. 03/2011
“Testing for Drug Allergy” (Symposium) AAAAI Annual Meeting. San Francisco, CA. 03/2011.
“Outpatient Evaluation of Patients with Multiple Drug Allergy Syndrome’ (Seminar) AAAAI Annual Meeting. Orlando, FL. 03/2012
“Multiple Drug Allergy Syndrome: Role of Graded Challenge and Desensitization” California Society of Allergy, Asthma, and Immunology Annual Meeting. San Francisco, CA. 07/2012.
“Update on Allergy to Penicillins and Other β-lactam Antibiotics” California Society of Allergy, Asthma and Immunology Annual Meeting. San Francisco, CA. 07/2012.
“Drug Allergy” (Meet the Professor Seminar) ACAAI Annual Meeting. Anaheim CA. 11/2012.
“Overview of Penicillin and β-lactam Allergy: Epidemiology, Cross- Reactivity, Costs of Utility of Penicillin Skin Testing” (Course) AAAAI Annual Meeting. San Antonio TX. 02/2013.
“Multiple Antibiotic Allergies” (Workshop) AAAAI Annual Meeting. San Antonio TX. 02/2013.
“Drug Allergy: An Overview” (Workshop) AAAAI Annual Meeting. San Diego, CA. 2/2007.
“Update on Allergic Rhinitis” Grand Rounds. Salem Hospital. Salem, OR. 2005.
“Diagnosis and Management of Reactions to Antibiotics” (Symposium) AAAAI Annual Meeting 2005.
“Antibiotic Allergy: What’s New?” (Workshop) AAAAI Annual Meeting. 2005.
“Adverse Reactions to Drugs” (Workshop) AAAAI Annual Meeting. 2005.
“Mechanisms of Allergy – A review” (Seminar) AAAAI Annual Meeting. 2005.
“Antibiotic Allergy” Grand Rounds. Johns Hopkins University/Sinai Hospital. Baltimore , MD 2005
“Asthma in 2004” Grand Rounds. Good Samaritan Regional Medical Center. Corvallis, OR 2004
“Antibiotic allergy” Grand Rounds. Kaiser Foundation Hospital. Santa Clara, CA 2004
“β-lactam allergy – management update” (Symposium) AAAAI Annual Meeting, 2004
“Approach to the multiple drug allergic patient” (Workshop) AAAAI Annual Meeting. 2004
“Office management of multiple antibiotic sensitivity” (Seminar) AAAAI annual Meeting. 2004
“Antibiotic allergy” Northwest Society of Nurses Annual Meeting. 2003
“Pediatric asthma update” Grand Rounds. Silverton Hospital. Silverton, OR 2003
“Practical approaches to β-lactam allergy” (Symposium) AAAAI Annual Meeting. 2003
“Evaluation and management of antibiotic hypersensitivity” (Workshop) AAAAI Annual Meeting. 2003
“Allergic rhinitis” Grand Rounds. Good Samaritan Regional Medical Center. Corvallis, OR 2003
<“Allergy to penicillin and other β-lactam antibiotics” Grand Rounds Good Samaritan Regional Medical Center, Corvallis, OR 2003
“Hypersensitivity to β-lactam antibiotics” Grand Rounds Albany General Hospital. Albany, OR 2002
“Treatment options for asthma” American Lung Association annual school nurses educational program Hartford, CT 2002
Publications
Solensky R. The time for penicillin skin testing is here (editorial). J Allergy Clin Immunology: In Practice 2013; 1:264-5.
Solensky R. Allergy to b-lactam antibiotics. J Allergy Clin Immonol 2012; 130:1442-1442e5.
Solensky R. Hypersensitivity reactions to macrolides, aminoglycosides, teracyclines, clindamycin, and metronidazole. In: UpToDate, Basow, DS (Editor), UpToDate, Waltham, MA 2012-present.
Solensky R. Medlelson LM. Drug allergy. In: Leung DYM, Sampson HA, Geha R, Sezfler SJ, editors. Pediatric Allergy: Principles and Practice. 2nd Edinburgh; Saunders, 2010; 616-30.
Solensky R. Khan D, Bernstein IL, Bloomberg GR, Castells MC, Mendelson LM, Weiss ME, Blessing-Moore J, Cox L, Land DM, Niklas RA, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles SA, Wallace D. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol 2010; 105: 259-273.e78.
Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol; 2010; 125:S126-37.
Castells MC, Solensky R. Rapid drug desensitization for immediate hypersensitivity reactions. In: UpToDate Bassow, DS (Editor), UpToDate, Waltham, MA, 2010-present.
Solensky R. Penicillin skin testing. In: UpToDate, Basow, DS (Editor), UpToDate, Waltham, MA, 2008-present.
Solensky R. “Allergy to Penicillins”. UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2008
Solensky, R. “Use of Cephalosporins, Carbapenems, and Monobactams in Penicillin Allergic Patients” UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2008
Solensky, R. “Evaluation of Penicillin Allergy without Benzylpenicoyl-polylsine (letter). Ann Allergy Asthma Immunol 2007; 98:402-3
Solensky, R. “Desensitization with Antibiotics”. Pichler WJ, editor. Drug Hypersensitivity. Basel: Karger 2007; 402-10
Solensky R. “Drug Hypersensitivity.” Med Clin North Am 2006; 90:233-60.
Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstein IL, Nickla RA, Anderson JA, Bernstein DI, Bernstein JA, Fink JN, Greenberger PA, Ledford DK, Li J, Sheffer AL, Solensky R, Wolf BL, Blessing-Moore J, Khan DA, Lee RE, Portnoy JM, Schuller De, Spector SL, Tilles SA. The diagnosis and management of anaphylaxis: An updated practice parameter. J Allergy Clin Immunol 2005; 115:S483-523.
Daulat SB, Solensky R, Earl H. Casey W., Grushalla R. “Safety of cephalosporin administration to patients with histories of penicillin allergy.” J. Allergy Clin Immunol 2004; 113-1220-2
Solensky R. “Drug desensitization.” Immunol Allergy Clinics North Am 2004; 24-425-43.
Solensky R. “Drug Allergy: Desensitization and treatment of reactions to antibiotics and aspirin.” In: Lockey RF, Bukantz SC, Bousquet J, editors. Allergens and Allergen Immunotherapy for Allergic Diseases. New York: Marcel Dekker, 2004; 585-606
Solensky R. “Resolution of fish allergy: A case report.” Ann Allergy Asthma Immunol 2003; 91:411-2
Solensky R, Mendelson LM. Drug allergy. In: Leung DYM, Sampson HA, Geha RS, Szefler SJ, editors. Pediatric Allergy: Principles and Practice. Philadelpha: Harcourt, 2003; 611-23
Solensky R. “Hypersensitivity reactions to beta-lactam antibiotics.” Clin Rev Allergy Immunol 2003; 24:201-19.
Solensky R, Earl HS, Gruchalla RS. “Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses.” Arch Intern Med 2002; 12:822-826.
Solensky R, Mendelson LM. “Systemic reactions to antibiotics.” Immunol Allergy Clinics North Am 2001; 21:679-697.
Solensky R, Gruchalla RS. “Nonanaphylactic drug disorders.” In: Schwartz L, Zweiman B., editors. Inflammatory Mechanisms in Allergic Diseases. New York: Marcel Dekker, 2001; 411-433
Solensky R, Gruchalla RS. “Penicillin sensitivity: How you can identify at–risk patients.” J Resp Dis 2001; 22:340
Solensky R, Earl HS, Gruchalla RS. “Penicillin allergy: Prevalence of vague history in skin test-positive patients.” Ann Allergy Asthma Immunol 2000; 85:195-199
Patient Ratings
The Patient Rating score is an average of all responses to care provider related questions on the Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments From Patients
Greatest ever would never go anywhere else
Really liked Dr. Solensky!
Dr Solensky is a great doctor. I would recommend him to others.
Trusted DR.
Very knowledgable and helpful. Explained things well and kindly to us.
Click on the appropriate link below to enter your provider’s telemedicine waiting room for your scheduled appointment.
